Exact Mass: 517.1510862

Exact Mass Matches: 517.1510862

Found 14 metabolites which its exact mass value is equals to given mass value 517.1510862, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

methyl (2S)-6-[(beta-D-glucopyranosyl)oxy]-2,3-dihydro-5-hydroxy-1-[(2E)-3-(4-hydroxyphenyl)prop-2-enoyl]-1H-indole-2-carboxylate|oleracein G

methyl (2S)-6-[(beta-D-glucopyranosyl)oxy]-2,3-dihydro-5-hydroxy-1-[(2E)-3-(4-hydroxyphenyl)prop-2-enoyl]-1H-indole-2-carboxylate|oleracein G

C25H27NO11 (517.1584032000001)


   

9,10-Dihydro-9,10-bis(2-carboxyethyl)-N-(4-nitrophenyl)-10,9-(epoxyimino)anthracene-12-carboxamide

9,10-Dihydro-9,10-bis(2-carboxyethyl)-N-(4-nitrophenyl)-10,9-(epoxyimino)anthracene-12-carboxamide

C27H23N3O8 (517.1485078000001)


   

Agerafenib

Agerafenib

C24H22F3N5O5 (517.1572958)


C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C61074 - Serine/Threonine Kinase Inhibitor C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C2336 - Raf Kinase Inhibitor C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor D004791 - Enzyme Inhibitors > D047428 - Protein Kinase Inhibitors Agerafenib (CEP-32496; RXDX-105) is a highly potent and orally efficacious inhibitor of BRAFV600E with a Kd of 14 nM.

   

2-[Bis(2-methylpropoxy)phosphoryl]-3,3,3-trifluoro-2-[(4-methylphenyl)sulfonylamino]propanoic acid ethyl ester

2-[Bis(2-methylpropoxy)phosphoryl]-3,3,3-trifluoro-2-[(4-methylphenyl)sulfonylamino]propanoic acid ethyl ester

C20H31F3NO7PS (517.1510862)


   

2-N,N-dihydroxy-nocardicin c

2-N,N-dihydroxy-nocardicin c

C23H25N4O10- (517.157061)


   

4-(5-carboxypentyl)-N-[(5-chloro-3,4-dihydro-8-hydroxy-3-methyl-1-oxo-1H-2-benzopyran-7-yl)carbonyl]-L-phenylalanine

4-(5-carboxypentyl)-N-[(5-chloro-3,4-dihydro-8-hydroxy-3-methyl-1-oxo-1H-2-benzopyran-7-yl)carbonyl]-L-phenylalanine

C26H28ClNO8 (517.1503358000001)


   

Mycothiol sulfinamide

Mycothiol sulfinamide

C17H31N3O13S (517.1577516)


The sulfinamide of mycothiol.

   

(3-aminopropyl)(L-aspartyl-1-amino)phosphoryl-5-adenosine(1-)

(3-aminopropyl)(L-aspartyl-1-amino)phosphoryl-5-adenosine(1-)

C17H26N8O9P- (517.1560296)


   

(2s,3s,4r,5r,6s)-4,5-bis(acetyloxy)-6-({4,8-dimethoxyfuro[2,3-b]quinolin-7-yl}oxy)-2-methyloxan-3-yl acetate

(2s,3s,4r,5r,6s)-4,5-bis(acetyloxy)-6-({4,8-dimethoxyfuro[2,3-b]quinolin-7-yl}oxy)-2-methyloxan-3-yl acetate

C25H27NO11 (517.1584032000001)


   

methyl (2s)-5-hydroxy-1-[(2e)-3-(4-hydroxyphenyl)prop-2-enoyl]-6-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-2,3-dihydroindole-2-carboxylate

methyl (2s)-5-hydroxy-1-[(2e)-3-(4-hydroxyphenyl)prop-2-enoyl]-6-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-2,3-dihydroindole-2-carboxylate

C25H27NO11 (517.1584032000001)


   

4,5-bis(acetyloxy)-6-({4,8-dimethoxyfuro[2,3-b]quinolin-7-yl}oxy)-2-methyloxan-3-yl acetate

4,5-bis(acetyloxy)-6-({4,8-dimethoxyfuro[2,3-b]quinolin-7-yl}oxy)-2-methyloxan-3-yl acetate

C25H27NO11 (517.1584032000001)


   

(2r,3r,4s,5r,6s)-4,5-bis(acetyloxy)-6-({4,8-dimethoxyfuro[2,3-b]quinolin-7-yl}oxy)-2-methyloxan-3-yl acetate

(2r,3r,4s,5r,6s)-4,5-bis(acetyloxy)-6-({4,8-dimethoxyfuro[2,3-b]quinolin-7-yl}oxy)-2-methyloxan-3-yl acetate

C25H27NO11 (517.1584032000001)


   

methyl 5-hydroxy-1-[3-(4-hydroxyphenyl)prop-2-enoyl]-6-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-2,3-dihydroindole-2-carboxylate

methyl 5-hydroxy-1-[3-(4-hydroxyphenyl)prop-2-enoyl]-6-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-2,3-dihydroindole-2-carboxylate

C25H27NO11 (517.1584032000001)